181 related articles for article (PubMed ID: 33278588)
1. Long-term effect of TNF inhibitors on radiographic progression in ankylosing spondylitis is associated with time-averaged CRP levels.
Konsta M; Sakellariou GT; Rusman T; Sfikakis PP; Iliopoulos A; van der Horst-Bruinsma IE
Joint Bone Spine; 2021 May; 88(3):105111. PubMed ID: 33278588
[TBL] [Abstract][Full Text] [Related]
2. Impact of Tumor Necrosis Factor Inhibitor Versus Nonsteroidal Antiinflammatory Drug Treatment on Radiographic Progression in Early Ankylosing Spondylitis: Its Relationship to Inflammation Control During Treatment.
Park JW; Kim MJ; Lee JS; Ha YJ; Park JK; Kang EH; Lee YJ; Song YW; Lee EY
Arthritis Rheumatol; 2019 Jan; 71(1):82-90. PubMed ID: 29984487
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumor necrosis factor α inhibitors on spinal radiographic progression in patients with ankylosing spondylitis.
Jeong H; Eun YH; Kim IY; Park EJ; Kim H; Lee J; Jeon CH; Koh EM; Cha HS
Int J Rheum Dis; 2018 May; 21(5):1098-1105. PubMed ID: 29611287
[TBL] [Abstract][Full Text] [Related]
4. Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.
Maas F; Spoorenberg A; Brouwer E; Bos R; Efde M; Chaudhry RN; Veeger NJ; van Ooijen PM; Wolf R; Bootsma H; van der Veer E; Arends S
PLoS One; 2015; 10(4):e0122693. PubMed ID: 25879956
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive Protein Levels Demonstrate Predictive Value for Radiographic and Magnetic Resonance Imaging Outcomes in Patients with Active Ankylosing Spondylitis Treated with Golimumab.
Braun J; Baraliakos X; Hermann KG; Xu S; Hsu B
J Rheumatol; 2016 Sep; 43(9):1704-12. PubMed ID: 27422890
[TBL] [Abstract][Full Text] [Related]
6. Effect of TNF-inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta-analysis.
Ajrawat P; Touma Z; Sari I; Taheri C; Diaz Martinez JP; Haroon N
Int J Rheum Dis; 2020 Jun; 23(6):728-743. PubMed ID: 32419337
[TBL] [Abstract][Full Text] [Related]
7. Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry.
Popova V; Kissling S; Micheroli R; Bräm R; de Hooge M; Baraliakos X; Nissen MJ; Möller B; Exer P; Andor M; Distler O; Scherer A; Ospelt C; Ciurea A
Arthritis Res Ther; 2023 Mar; 25(1):40. PubMed ID: 36915202
[TBL] [Abstract][Full Text] [Related]
8. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort.
Molnar C; Scherer A; Baraliakos X; de Hooge M; Micheroli R; Exer P; Kissling RO; Tamborrini G; Wildi LM; Nissen MJ; Zufferey P; Bernhard J; Weber U; Landewé RBM; van der Heijde D; Ciurea A;
Ann Rheum Dis; 2018 Jan; 77(1):63-69. PubMed ID: 28939631
[TBL] [Abstract][Full Text] [Related]
9. Incorporation of the anteroposterior lumbar radiographs in the modified Stoke Ankylosing Spondylitis Spine Score improves detection of radiographic spinal progression in axial spondyloarthritis.
Llop M; Rios Rodriguez V; Redeker I; Sieper J; Haibel H; Rudwaleit M; Poddubnyy D
Arthritis Res Ther; 2019 May; 21(1):126. PubMed ID: 31126334
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Inflammation and Radiographic Progression in Patients With Ankylosing Spondylitis Attaining a BASDAI of Less Than 4 During Tumor Necrosis Factor Inhibitor Treatment.
Koo BS; Oh JS; Park SY; Shin JH; Nam B; Lee S; Joo KB; Kim TH
J Rheumatol; 2022 Dec; 49(12):1328-1334. PubMed ID: 35840153
[TBL] [Abstract][Full Text] [Related]
11. Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO.
Llop M; Moreno M; Navarro-Compán V; Juanola X; de Miguel E; Almodóvar R; Quintana EC; Sanz JS; Beltrán E; Montesinos MDR; Calvet J; Berenguer-Llergo A; Gratacós J;
Arthritis Res Ther; 2022 Jan; 24(1):30. PubMed ID: 35063018
[TBL] [Abstract][Full Text] [Related]
12. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial.
Braun J; Baraliakos X; Hermann KG; Deodhar A; van der Heijde D; Inman R; Beutler A; Zhou Y; Xu S; Hsu B
Ann Rheum Dis; 2014 Jun; 73(6):1107-13. PubMed ID: 23644549
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.
Maas F; Arends S; Brouwer E; Essers I; van der Veer E; Efde M; van Ooijen PMA; Wolf R; Veeger NJGM; Bootsma H; Wink FR; Spoorenberg A
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1011-1019. PubMed ID: 27696754
[TBL] [Abstract][Full Text] [Related]
14. A five-year prospective study of spinal radiographic progression and its predictors in men and women with ankylosing spondylitis.
Deminger A; Klingberg E; Geijer M; Göthlin J; Hedberg M; Rehnberg E; Carlsten H; Jacobsson LT; Forsblad-d'Elia H
Arthritis Res Ther; 2018 Aug; 20(1):162. PubMed ID: 30075808
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors.
Konsta M; Nurmohamed MT; Iliopoulos A; Sfikakis PP; van Denderen JC; Visman I; Sakelariou GT; van der Horst-Bruinsma IE
J Rheumatol; 2023 Mar; 50(3):342-350. PubMed ID: 36319019
[TBL] [Abstract][Full Text] [Related]
16. High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.
Poddubnyy D; Protopopov M; Haibel H; Braun J; Rudwaleit M; Sieper J
Ann Rheum Dis; 2016 Dec; 75(12):2114-2118. PubMed ID: 27125522
[TBL] [Abstract][Full Text] [Related]
17. The natural course of radiographic progression in ankylosing spondylitis--evidence for major individual variations in a large proportion of patients.
Baraliakos X; Listing J; von der Recke A; Braun J
J Rheumatol; 2009 May; 36(5):997-1002. PubMed ID: 19332632
[TBL] [Abstract][Full Text] [Related]
18. Factors Predictive of Radiographic Progression in Ankylosing Spondylitis.
Sari I; Lee S; Tomlinson G; Johnson SR; Inman RD; Haroon N
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):275-281. PubMed ID: 31675169
[TBL] [Abstract][Full Text] [Related]
19. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
20. Low bone mineral density of vertebral lateral projections can predict spinal radiographic damage in patients with ankylosing spondylitis.
Kim JW; Chung MK; Lee J; Kwok SK; Kim WU; Park SH; Ju JH
Clin Rheumatol; 2019 Dec; 38(12):3567-3574. PubMed ID: 31402392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
